Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy
between this translated document and the Japanese original, the original shall prevail.

October 27, 2022

Consolidated Financial Results
for the Six Months Ended September 30, 2022
(Under Japanese GAAP)

Company name: Taoka Chemical Co., Ltd
Listing:
Tokyo Stock Exchange
Securities code: 4113
URL:
https://www.taoka-chem.co.jp
Representative: Yasuaki Sasaki, President
Inquiries:
Yasuhito Katsumoto, General Manager, Business Services OfficeTelephone:+81-6-7639-7400
Scheduled date to file quarterly securities report:
November 10, 2022
Scheduled date to commence dividend payments:
December 2, 2022
Preparation of supplementary material on quarterly financial results: None
Holding of quarterly financial results briefing: Yes (for institutional investors and analysts)(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Consolidated financial results for the six months ended September 30, 2022 (from April 1,
2022 to September 30, 2022)(1) Consolidated operating results (cumulative)
Sales revenue
Six months ended

Millions ofyen%

15,264
16,855(9.4)
6.0

September 30, 2022
September 30, 2021
Note: Comprehensive income(Percentages indicate year-on-year changes.)

Operating income

Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen

Millions ofyen%

249 (86.4)
1,829
0.0%

279 (85.0)
1,867
0.3

191 (85.7)
1,336
5.4

For the six months ended September 30, 2022: ¥240 million [(81.9)%]
For the six months ended September 30, 2021: ¥1,329 million [4.0%]

Net income
per share

Diluted net incomeper share

Six months ended
September 30, 2022

13.35

－

September 30, 2021

93.25

－Yen%

Yen

Note: Effective on October 1, 2021, the Company split one common share into five shares. Net income per share
was calculated under the assumption that this stock split was conducted at the beginning of the previous
consolidated fiscal year.

(2) Consolidated financial position

Equity-to-asset
ratio

Total assets

Net assets

Millions of yen

Millions of yen%

32,641
32,417

16,732
16,74951.3
51.7

As ofSeptember 30, 2022
March 31, 2022

Reference: EquityAs of September 30, 2022:
As of March 31, 2022:¥16,732 million¥16,749 million

2. Cash dividends
Annual dividends per share
SecondThird
Fiscal yearquarter-end
quarter-endendFirst
quarter-end
Fiscal year ended
March 31, 2022
Fiscal year ending
March 31, 2023
Fiscal year ending
March 31, 2023
(Forecast)

Total

Yen

Yen

Yen

Yen

Yen

−

90.00

−

18.00

−−

18.00
−

9.00

27.00

Note: Revisions to the forecasts of cash dividends most recently announced: Yes
For details of the revisions to the dividend forecasts, please refer to “Differences between Financial
Forecasts and Actual Results for Six Months Ended September 30, 2022, and Revisions to Full-Year
Financial Forecasts and Year-End Dividend Forecasts,” disclosed on October 27, 2022.
Effective on October 1, 2021, the Company split one common share into five shares. The year-end dividend
per share for the fiscal year ended March 31, 2022 is stated by taking into account the effect of the stock
split, and the total annual dividend is stated as “−.” When the effect of the stock split is taken into account,the second quarter-end dividend per share and annual dividend per share for the fiscal year ended March31, 2022 will be ¥18.00 and ¥36.00, respectively.

3. Consolidated financial forecasts for the fiscal year ending March 31, 2023 (from April 1,2022 to March 31, 2023)(Percentages indicate year-on-year changes.)

Sales revenue

Full year

Millions ofyen%

31,000(4.2)

Operating income Ordinary income

Net income
attributable toowners of theparent

Millions ofyen

Millions ofyen%

500 (81.5)

Millions ofyen%

500 (82.1)

Netincomeper share%yen

300 (85.5)

20.94

Note: Revisions to the forecasts of consolidated financial results most recently announced: Yes
For details of the revisions to the consolidated financial forecasts, please refer to “Differences between
Financial Forecasts and Actual Results for Six Months Ended September 30, 2022, and Revisions to FullYear Financial Forecasts and Year-End Dividend Forecasts,” disclosed on October 27, 2022.

* Notes(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting
in the change in scope of consolidation): None
(2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financialstatements: Yes(3) Changes in accounting policies, changes in accounting estimates, and restatement(i) Changes in accounting policies due to revisions to accounting standards and otherregulations: None(ii) Changes in accounting policies due to other reasons: None(iii) Changes in accounting estimates: None(iv) Restatement: None
(4) Number of issued shares (common shares)(i) Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2022As of March 31, 2022

14,440,000 shares
14,440,000 shares(ii) Number of treasury shares at the end of the period
As of September 30, 2022
As of March 31, 2022

111,140 shares
111,140 shares(iii) Average number of shares outstanding during the period (cumulative from the beginning of
the fiscal year)
Six months ended September 30, 2022
Six months ended September 30, 2021

14,328,860 shares
14,328,860 shares

Note: Effective on October 1, 2021, the Company split one common share into five shares. The above numbers ofshares were calculated under the assumption that this stock split was conducted at the beginning of theprevious consolidated fiscal year.

* Quarterly financial results reports are exempt from quarterly review conducted by certified public
accountants or an audit corporation.
* Proper use of earnings forecasts, and other special matters(Caution regarding forward-looking statements and others)
The forward-looking statements, including financial forecasts, contained in this report are based on
information currently available to the Company and certain assumptions deemed to be reasonable.
Accordingly, they are not intended to be construed as assurance that they will be accomplished inthe future. Note that actual results may differ materially from the forecasts for a number of reasons.

The Taoka Chemical Group’s consolidated sales revenue for the six months ended September 30,
2022, decreased by ¥1,591 million compared with the same period of the previous fiscal year, to¥15,264 million. The Group posted operating income of ¥249 million, ordinary income of ¥279
million and net income attributable to owners of the parent of ¥191 million.
The financial results of Taoka Chemical by business segment for the six month period were as
follows:
Division

Six Months Ended Six Months Ended
September 30, 2021 September 30, 2022

ChangeMillions of Composition Millions of Composition Millions of Year-on-year
yenratio (%)
yenratio (%)
yenrate (%)

Fine Chemicals

9,996

59.3

7,343

48.1

(2,652)(26.5)

Functional Chemicals
Functional Polymers andAdditives
Chemicals Segment

1,964

11.7

1,638

10.7

(326)

(16.6)

4,604

27.3

5,981

39.2

1,376

29.9

16,56698.3

14,96398.0(1,602)(9.7)

Others289

1.73002.0

113.9

Total16,855

100.0

15,264100.0(1,591)(9.4)

Chemicals Segment
Sales revenue of this segment was ¥14,963 million, a ¥1,602 million decrease compared to thesame period of the previous fiscal year.
Fine Chemicals Division
Though shipments of agrochemical intermediates increased, shipments of monomers for opticalresins decreased. As a result, the division sales revenue decreased by ¥2,652 million, to ¥7,343
million.
Functional Chemicals Division
Shipments of adhesives and rubber additives decreased. As a result, the division sales revenue
decreased by ¥326 million to ¥1,638 million.
Functional Polymers and Additives Division
Though shipments of plasticizers and varnish decreased, their sales prices increased reflecting asteep rise in raw material prices. As a result, the division sales revenue increased by ¥1,376 million,to ¥5,981 million.
Others (Analytical Services)
Sales of evaluation of hazardous substances and asbestos analysis increased. As a result, thesegment sales revenue increased by ¥11 million, to ¥300 million.